Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Two-arm, Phase 2/3 Multicentre, Open-label, Randomised Study Evaluating Safety and Antiviral Effect of Current Standard Antiretroviral Therapy Compared to Once Daily Integrase Inhibitor Administered With Darunavir/Ritonavir (DRV/r) in HIV-1 Infected, Virologically Suppressed Paediatric Participants.
INTERVENTIONAL
Inicio: 1 de jun de 2016
ID: NCT02383108
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2 Open-Label Study in Infants With REspiratory Syncytial VIRus Lower RespirAtory Tract Infection, Followed by a DoubLe-blind, Placebocontrolled Part, to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Effect of RV521 (REVIRAL 1)
INTERVENTIONAL
Inicio: 13 de nov de 2019
ID: NCT04225897
Completado
ClinicalTrials.gov
CariesCare International Adapted for the Pandemic in Children: Caries OUT Multicentre Single-group Interventional Study
OBSERVATIONAL
Inicio: 15 de nov de 2020
ID: NCT04666597
Retirado
Fase 2
ClinicalTrials.gov
Safety and Efficacy of Inhaled XW001 (Interleukin 29 Analog for Nebulization) For Hospitalized COVID-19 Patients Requiring Oxygen Therapy: A Multiregional, Randomized, Double-blind, Placebo-controlled Study
INTERVENTIONAL
Inicio: 30 de oct de 2021
ID: NCT05083117
Completado
Fase 3
ClinicalTrials.gov
Phase3 Study to Evaluate the Efficacy and Safety of AlbuminInterferon in Combination With Ribavirin Compared With Peginterferon in Combination With Ribavirin in Interferon Alfa Naive Subjects With CHC Genotype 2/3.
INTERVENTIONAL
Inicio: 1 de feb de 2007
ID: NCT00411385
Completado
Fase 3
ClinicalTrials.gov
A Multi-centre Long Term Follow-up Study to Assess the Durability of Sustained Virologic Response in Alisporivir-treated Chronic Hepatitis C Patients
INTERVENTIONAL
Inicio: 1 de dic de 2011
ID: NCT02753699
Terminado
ClinicalTrials.gov
Integration of Electronic SBI(RT) Into an HIV Testing Program to Reduce Substance Use and HIV Risk Behavior Among MSM in Argentina
INTERVENTIONAL
Inicio: 1 de nov de 2022
ID: NCT05542914
Completado
Fase 3
ClinicalTrials.gov
Randomized, Open Label Study Evaluating the Lipid Profile Difference and Efficacy of a Combined Therapy Including Tenofovir, Emtricitabine + Atazanavir / r or NVP in Naive HIV - 1 Infected Patients.
INTERVENTIONAL
Inicio: 1 de oct de 2006
ID: NCT00389207
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Active Comparator-controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older
INTERVENTIONAL
Inicio: 7 de nov de 2022
ID: NCT05569954
Completado
Fase 3
ClinicalTrials.gov
A Study to Compare Long-Term Safety and Tolerability of Stavudine (d4T) Extended Release (ER) Versus Conventional (Immediate Release, IR) Formulations, Each In Combination With Lamivudine (3TC) and Efavirenz (EFV) in Subjects Who Have Completed BMS Studies AI455-096 and AI455-099
INTERVENTIONAL
Inicio: 1 de ene de 2001
ID: NCT00116298
Completado
Fase 4
ClinicalTrials.gov
Pilot Study of Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women
INTERVENTIONAL
Inicio: 1 de dic de 2015
ID: NCT03033836
Completado
Fase 3
ClinicalTrials.gov
A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Naïve Women
INTERVENTIONAL
Inicio: 22 de ago de 2013
ID: NCT01910402
Desconocido
Fase 4
ClinicalTrials.gov
A Pilot Randomized, Open Label Study to Evaluate Efficacy and Safety of the Combination of RAL+ATV/r in Comparison With TDF/FTC+ATV/r in HIV Infected Patients, Who Failed an Initial NNRTI Containing Regimen
INTERVENTIONAL
Inicio: 1 de may de 2014
ID: NCT01829802
Completado
Fase 3
ClinicalTrials.gov
A Stage 2/3, Adaptive, Randomized, Controlled, Double-blind Study to Investigate the Pharmacokinetics, Efficacy and Safety of the Hyperimmune Equine Serum (INM005) in Adult Patients With Moderate to Severe Confirmed SARS-CoV2 Disease.
INTERVENTIONAL
Inicio: 27 de jul de 2020
ID: NCT04494984
Completado
Fase 2
ClinicalTrials.gov
An Open-label Study of Liquid and Sprinkled Formulations of Efavirenz Administered in Combination With Didanosine and Emtricitabine in HIV-infected Infants and Children 3 Months to 6 Years of Age.
INTERVENTIONAL
Inicio: 1 de feb de 2007
ID: NCT00364793
Completado
ClinicalTrials.gov
Individualized Antiretroviral Therapy: Impact of Pharmacogenetic and Therapeutic Drug Monitoring in the Safety and Efficacy of First Line Antiretroviral Therapy in Patients With HIV Infection
INTERVENTIONAL
Inicio: 5 de oct de 2017
ID: NCT03385473
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of VAY736 in Autoimmune Hepatitis
INTERVENTIONAL
Inicio: 15 de feb de 2018
ID: NCT03217422
Completado
Fase 2
ClinicalTrials.gov
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
INTERVENTIONAL
Inicio: 27 de jul de 2020
ID: NCT04449029
Completado
Fase 4
ClinicalTrials.gov
Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3
INTERVENTIONAL
Inicio: 17 de may de 2021
ID: NCT04880395
Completado
Fase 2
ClinicalTrials.gov
A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected or Confirmed Gram-negative Severe Sepsis in Adults
INTERVENTIONAL
Inicio: 1 de sept de 2004
ID: NCT00089986
Anterior
1
...
35
36
37
...
434
Siguiente
Filtros